Calmodulin inhibitor trifluoperazine selectively enhances cytotoxic effects of strong VS weak DNA binding antitumor drugs in doxorubicin-resistant P388 mouse leukemia cells

This publication has 10 references indexed in Scilit:

• Mechanisms regulating cell resistance to adriamycin evidence that drug accumulation in resistant cells is modulated by phosphorylation of a plasma membrane glycoprotein
  Biochemical Pharmacology, 1985
• Correlation between potency of calmodulin inhibitors and effects on cellular levels and cytotoxic activity of Doxorubicin (Adriamycin) in resistant P388 mouse leukemia cells
  European Journal of Cancer and Clinical Oncology, 1984
• DIFFERENTIAL EFFECT OF THE CALMODULIN INHIBITOR TRIFLUOPERAZINE ON CELLULAR ACCUMULATION, RETENTION, AND CYTO-TOXICITY OF ANTHRACYCLINES IN DOXORUBICIN (ADRIAMYCIN)-RESISTANT P388 MOUSE LEUKEMIA-CELLS
  1984
• DAUNORUBICIN-RESISTANT CHINESE-HAMSTER OVARY CELLS EXPRESSING MULTIDRUG RESISTANCE AND A CELL-SURFACE P-GLYCOPROTEIN
  1983
• ENHANCEMENT OF SENSITIVITY TO ADRIAMYCIN IN RESISTANT P388-LEUKEMIA BY THE CALMODULIN INHIBITOR TRIFLUOPERAZINE
  1983
• INCREASED ACCUMULATION OF VINCRISTINE AND ADRIAMYCIN IN DRUG-RESISTANT P388-TUMOR CELLS FOLLOWING INCUBATION WITH CALCIUM-ANTAGONISTS AND CALMODULIN INHIBITORS
  1982
• ACTIVE EFFLUX OF DAUNORUBICIN AND ADRIAMYCIN IN SENSITIVE AND RESISTANT SUBLINES OF P388-LEUKEMIA
  1979
• MECHANISMS OF RESISTANCE TO DAUNORUBICIN IN EHRLICH ASCITES TUMOR-CELLS
  1978
• INVIVO CHARACTERISTICS OF RESISTANCE AND CROSS-RESISTANCE OF AN ADRIAMYCIN-RESISTANT SUBLINE OF P388 LEUKEMIA
  1978
• Adriamycin—A Review
  JNCI Journal of the National Cancer Institute, 1975